CervoMed's stock soars 400% on promising dementia drug data. See more on insights, potential concerns, and what it means for ...
After much deliberation, the FDA has granted accelerated approval for Biogen’s tofersen for an ultra-rare form of the neurodegenerative disease amyotrophic lateral sclerosis, associated with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback